Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000168213 | SCV000218879 | pathogenic | Hereditary spastic paraplegia 11 | 2023-02-24 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Cys959*) in the SPG11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SPG11 are known to be pathogenic (PMID: 19105190, 20110243, 22154821, 26556829). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with SPG11-related conditions (PMID: 3283541, 32383541). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 188250). For these reasons, this variant has been classified as Pathogenic. |
Center for Genomic Medicine, |
RCV000171235 | SCV000221432 | likely pathogenic | not provided | criteria provided, single submitter | research | ||
Gene |
RCV000171235 | SCV004167998 | pathogenic | not provided | 2023-04-05 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 27124789, 32383541) |